This is a preprint.
Suspended Tissue Open Microfluidic Patterning (STOMP)
- PMID: 39416011
- PMCID: PMC11482760
- DOI: 10.1101/2024.10.04.616662
Suspended Tissue Open Microfluidic Patterning (STOMP)
Update in
-
Suspended Tissue Open Microfluidic Patterning (STOMP).Adv Sci (Weinh). 2025 Jul;12(25):e2501148. doi: 10.1002/advs.202501148. Epub 2025 Apr 29. Adv Sci (Weinh). 2025. PMID: 40298902 Free PMC article.
Abstract
Free-standing tissue structures tethered between pillars are powerful mechanobiology tools for studying cell contraction. To model interfaces ubiquitous in natural tissues and upgrade existing single-region suspended constructs, we developed Suspended Tissue Open Microfluidic Patterning (STOMP), a method to create multiregional suspended tissues. STOMP uses open microfluidics and capillary pinning to pattern subregions within free-standing tissues, facilitating the study of complex tissue interfaces, such as diseased-healthy boundaries (e.g., fibrotic-healthy) and tissue-type interfaces (e.g., bone-ligament). We observed altered contractile dynamics in fibrotic-healthy engineered heart tissues compared to single-region tissues and differing contractility in bone-ligament enthesis constructs compared to single-tissue periodontal ligament models. STOMP is a versatile platform - surface tension-driven patterning removes material requirements common with other patterning methods (e.g., shear-thinning, photopolymerizable) allowing tissue generation in multiple geometries with native extracellular matrices and advanced 4D materials. STOMP combines the contractile functionality of suspended tissues with precise patterning, enabling dynamic and spatially controlled studies.
Conflict of interest statement
AJH, LGB, AG, PM, AV, TL, SN, AL, JMW, RB, EB, CAD, NS, and ABT filed patent 18/669,367 and AJH, LGB, JMW, AV, CAD, NJS, EEB, EB, and ABT filed patent 63/665,194 through the University of Washington on STOMP and a related technology. ABT reports filing multiple patents through the University of Washington and receiving a gift to support research from Ionis Pharmaceuticals. EB and ABT have ownership in Seabright, LLC, which will advance new tools for diagnostics and clinical research. EB has ownership in Salus Discovery, LLC, and Tasso, Inc. and is employed by Tasso, Inc. NJS has ownership in Stasys Medical Corporation, Inc. and has ownership and is a scientific advisor in Curi Bio, Inc. Technologies from Seabright, LLC, Salus Discovery, LLC, Tasso, Inc., Stasys Medical Corporation, Inc, and Curi Bio, Inc. are not included in this publication. EB is an inventor on multiple patents filed by Tasso, Inc., the University of Washington, and the University of Wisconsin-Madison. The terms of this arrangement have been reviewed and approved by the University of Washington in accordance with its policies governing outside work and financial conflicts of interest in research. All other authors declare they have no competing interests.
Figures





References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources